General MedicationsORALGeneric

AZDONE

ASPIRIN; HYDROCODONE BITARTRATE

Standard Dose

500MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview AZDONE is listed in Drugs@FDA under application 089420 (ANDA).

Marketing status: Discontinued Active ingredient ASPIRIN; HYDROCODONE BITARTRATE Form and strength TABLET;ORAL - 500MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SCHWARZ PHARMA Submission history Latest submission status date: 1999-11-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview AZDONE is listed in Drugs@FDA under application 089420 (ANDA). Marketing status: Discontinued Active ingredient ASPIRIN; HYDROCODONE BITARTRATE Form and strength TABLET;ORAL - 500MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SCHWARZ PHARMA Submission history Latest submission status date: 1999-11-29 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.